| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.78B | 18.63B | 19.11B | 17.93B | 34.54B | 22.27B |
| Gross Profit | 895.60M | 1.53B | 3.25B | 4.96B | 18.09B | 9.82B |
| EBITDA | 2.63B | 3.17B | 5.01B | 5.20B | 19.29B | 10.83B |
| Net Income | 247.80M | 909.80M | 2.39B | 2.94B | 17.03B | 9.07B |
Balance Sheet | ||||||
| Total Assets | 29.90B | 28.96B | 33.62B | 29.01B | 38.69B | 26.71B |
| Cash, Cash Equivalents and Short-Term Investments | 3.34B | 3.48B | 7.57B | 7.65B | 18.08B | 7.75B |
| Total Debt | 6.51B | 6.39B | 6.61B | 5.03B | 5.44B | 5.50B |
| Total Liabilities | 11.58B | 10.97B | 12.89B | 10.25B | 10.78B | 10.55B |
| Stockholders Equity | 18.07B | 17.93B | 20.65B | 18.69B | 27.89B | 16.15B |
Cash Flow | ||||||
| Free Cash Flow | 863.40M | 985.10M | 2.20B | 3.26B | 18.06B | 9.16B |
| Operating Cash Flow | 1.71B | 2.44B | 4.36B | 4.97B | 19.50B | 10.41B |
| Investing Cash Flow | -884.10M | -1.53B | -1.98B | -1.65B | -4.07B | -1.23B |
| Financing Cash Flow | -2.63B | -2.33B | -3.08B | -12.18B | -8.23B | -2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | €770.44M | 12.67 | 16.03% | 5.12% | -5.58% | -5.61% | |
66 Neutral | €2.63B | 33.06 | 7.38% | 1.97% | -5.40% | -8.25% | |
61 Neutral | €10.21B | 96.19 | 10.96% | 0.68% | 10.84% | 7.53% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | €19.51B | 81.59 | 4.94% | 7.14% | -10.66% | -90.22% | |
43 Neutral | €2.11B | 770.81 | 0.36% | 0.47% | 6.05% | -716.00% |